Very high GR expression relative to other regions has been observed in the neonatal rat cerebellum (48), and exogenous GC treatments can reduce cerebellar volume and initiate long-term cognitive impairments in children (49, 50). The gene discussed is NR3C1; the disease is Cognitive impairment.